Lv11
66 积分 2025-06-30 加入
Enhanced interpretation of secondary pharmacology data through automated visualization tools to support safety assessment
8小时前
已完结
Hypophagia and body weight loss by tirzepatide are accompanied by fewer GI adverse events compared to semaglutide in preclinical models
15天前
已完结
Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider
28天前
已完结
Off-target effects of oligonucleotides and approaches of preclinical assessments
29天前
已完结
A practical guide to secondary pharmacology in drug discovery
1个月前
已完结
Derivation of subacute guidance values for chemical contaminants of drinking water quality standard in Japan
1个月前
已完结
Regulatory Experience Assessing the Carcinogenic Potential of a Monoclonal Antibody Inhibiting PCSK9, Bococizumab, Including a 2-Year Carcinogenicity Study in Rats
2个月前
已完结
Safety considerations for cereblon-recruiting targeted protein degraders
3个月前
已完结
A Fluorescence-Based Reporter Gene Assay to Characterize Nuclear Receptor Modulators
4个月前
已完结
Application of transporter assays for drug discovery and development: an update of the literature
4个月前
已完结
皖公网安备34019202002308
